125 lines
49 KiB
Text
125 lines
49 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK547963">
|
|
<meta name="ncbi_domain" content="livertox">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK547963/?report=reader">
|
|
<meta name="ncbi_pagename" content="Trisalicylate - LiverTox - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Trisalicylate - LiverTox - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/livertox/Triptorelin/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/livertox/Troglitazone/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/livertox/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]">
|
|
<meta name="citation_title" content="Trisalicylate">
|
|
<meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases">
|
|
<meta name="citation_date" content="2020/08/15">
|
|
<meta name="citation_pmid" content="31643296">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK547963/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Trisalicylate">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases">
|
|
<meta name="DC.Date" content="2020/08/15">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK547963/">
|
|
<meta name="description" content="Choline magnesium trisalicylate is a nonacetylated dimer of salicylic acid that is used in the therapy of chronic arthritis and for general management of pain and fever. Trisalicylate has been linked to rare instances of acute, clinically apparent liver injury.">
|
|
<meta name="og:title" content="Trisalicylate">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="Choline magnesium trisalicylate is a nonacetylated dimer of salicylic acid that is used in the therapy of chronic arthritis and for general management of pain and fever. Trisalicylate has been linked to rare instances of acute, clinically apparent liver injury.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK547963/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/livertox/Trisalicylate/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK547963/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8CD38C7D7FFBC10000000000060004.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK547963/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/livertox/Triptorelin/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Trisalicylate</div><div class="j">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</div></div><div class="tail"><a href="/books/n/livertox/Troglitazone/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK547963/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK547963/&text=Trisalicylate"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/livertox/?report=reader">Title Information</a><a href="/books/n/livertox/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK547963/?report=classic">Switch to classic view</a><a href="/books/NBK547963/pdf/Bookshelf_NBK547963.pdf">PDF (110K)</a><a href="/books/NBK547963/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK547963%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8CD38C7D7FFBC10000000000060004.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK547963_"><span class="title" itemprop="name">Trisalicylate</span></h1><p class="fm-aai"><a href="#_NBK547963_pubdet_">Publication Details</a></p></div></div><div class="body-content whole_rhythm" itemprop="text"><div id="Trisalicylate.OVERVIEW"><h2 id="_Trisalicylate_OVERVIEW_">OVERVIEW</h2><div id="Trisalicylate.Introduction"><h3>Introduction</h3><p>Choline magnesium trisalicylate is a nonacetylated dimer of salicylic acid that is used in the therapy of chronic arthritis and for general management of pain and fever. Trisalicylate has been linked to rare instances of acute, clinically apparent liver injury.</p></div><div id="Trisalicylate.Background"><h3>Background</h3><p>Trisalicylate (trye" sa lis' i late) is a nonacetylated salicylic acid that has antiinflammatory, analgesic and antipyretic actions similar to aspirin. The antiinflammatory and analgesic effects of trisalicylate are probably mediated by its inhibition prostaglandin synthesis. Choline magnesium trisalicylate is similar in efficacy to aspirin, but is reported to have fewer side effects. Although available for several decades, it is less commonly used than typical nonsteroidal antiinflammatory agents. Trisalicylate is indicated for the treatment of chronic arthritis due to osteoarthritis or rheumatoid arthritis and for minor-to-moderate pain. Trisalicylate is available by prescription only as tablets of 500, 750 and 1000 mg in generic forms and under the brand name of Trilisate. It is also available as an oral solution. The recommended regimen is 750 to 1500 mg twice daily, based upon response and tolerance. Common side effects are intestinal upset, nausea, headache, dizziness, somnolence, tinnitus, rash and hypersensitivity reactions.</p></div><div id="Trisalicylate.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Prospective studies show that a proportion of patients taking choline magnesium trisalicylate experience at least transient serum aminotransferase elevations. These may resolve even with drug continuation, particularly if the dose is reduced. Marked aminotransferase elevations (>3 fold elevated) can occur with high doses in patterns that resemble aspirin induced hepatotoxicity. At least one instance of clinically apparent liver injury with jaundice has been reported with onset within a week of starting trisalicylate and characterized by a mixed pattern of enzyme elevations and potentially severe course. Fever, rash and eosinophilia did not occur and autoantibodies were not present. Trisalicylate is probably capable of inducing Reye syndrome in a susceptible child or adolescent and, like aspirin, should be avoided in those age groups.</p><p>Likelihood score: A[HD]: (well established cause of clinically apparent liver injury when given in high doses).</p></div><div id="Trisalicylate.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The mechanism of trisalicylate hepatotoxicity is likely hypersensitivity in instances of jaundice associated with standard doses. In addition, trisalicylate in high doses probably has a direct hepatotoxic effect resembling that of aspirin.</p></div><div id="Trisalicylate.Outcome_and_Management"><h3>Outcome and Management</h3><p>A single case report of acute liver failure with ultimate recovery has been published. No instances of chronic liver disease or vanishing bile duct syndrome due to trisalicylate have been published. Patients with hypersensitivity to trisalicylate should probably avoid other nonacetylated salicylates.</p><p>Drug Class: <a href="/books/n/livertox/Salicylates/?report=reader">Salicylates</a></p><p>Other Drugs in the Class: <a href="/books/n/livertox/Aspirin/?report=reader">Aspirin</a>, <a href="/books/n/livertox/Diflunisal/?report=reader">Diflunisal</a>, <a href="/books/n/livertox/Salsalate/?report=reader">Salsalate</a></p></div></div><div id="Trisalicylate.CASE_REPORT"><h2 id="_Trisalicylate_CASE_REPORT_">CASE REPORT</h2><div id="Trisalicylate.Case_1_Serum_enzyme_elevat"><h3>Case 1. Serum enzyme elevations during choline magnesium trisalicylate therapy.(<a class="bibr" href="#Trisalicylate.REF.1" rid="Trisalicylate.REF.1">1</a>)</h3><p>A 21 year old woman had systemic lupus erythematosus, but was on no specific therapy. She developed a persistent cough that was then followed by fever, headache and fatigue. Evaluation found no specific cause and she was started on trisalicylate in a dose of 1500 mg twice daily to treat a suspected worsening of the underlying lupus erythematosus. Within four days, serum enzymes which had been mildly abnormal began to rise (Table). Trisalicylate was stopped and one day later serum ALT levels began to fall, although they were still elevated at the time of discharge and no follow up was available. Testing done on admission suggested that the fever and cough were due to cytomegalovirus infection and not to worsening of lupus erythematosus.</p><div id="Trisalicylate.Key_Points"><h4>Key Points</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figTrisalicylateTc"><a href="/books/NBK547963/table/Trisalicylate.Tc/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figTrisalicylateTc" rid-ob="figobTrisalicylateTc"><img class="small-thumb" src="/books/NBK547963/table/Trisalicylate.Tc/?report=thumb" src-large="/books/NBK547963/table/Trisalicylate.Tc/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Trisalicylate.Tc"><a href="/books/NBK547963/table/Trisalicylate.Tc/?report=objectonly" target="object" rid-ob="figobTrisalicylateTc">Table</a></h4></div></div></div><div id="Trisalicylate.Laboratory_Values"><h4>Laboratory Values</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figTrisalicylateTd"><a href="/books/NBK547963/table/Trisalicylate.Td/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figTrisalicylateTd" rid-ob="figobTrisalicylateTd"><img class="small-thumb" src="/books/NBK547963/table/Trisalicylate.Td/?report=thumb" src-large="/books/NBK547963/table/Trisalicylate.Td/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Trisalicylate.Td"><a href="/books/NBK547963/table/Trisalicylate.Td/?report=objectonly" target="object" rid-ob="figobTrisalicylateTd">Table</a></h4></div></div></div><div id="Trisalicylate.Comment"><h4>Comment</h4><p>A typical pattern of serum enzyme elevation in salicylate hepatotoxicity occurring within days of starting therapy with choline magnesium trisalicylate and improving within a few days of stopping. CMV hepatitis is also a possibility, although the timing in relationship to starting the medication favors drug induced liver injury. Salicylate hepatotoxicity is generally asymptomatic, anicteric and rapidly reversible.</p></div></div></div><div id="Trisalicylate.PRODUCT_INFORMATION"><h2 id="_Trisalicylate_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><p>
|
|
<b>REPRESENTATIVE TRADE NAMES</b>
|
|
</p><p>Trisalicylate – Generic, Trilisate® (not available in U.S.), Generic</p><p>
|
|
<b>DRUG CLASS</b>
|
|
</p><p>Antiinflammatory Agents</p><p>
|
|
<a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac5d0d81-5c64-4344-850d-34946b3252b1" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">COMPLETE LABELING</a>
|
|
</p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div><div id="Trisalicylate.CHEMICAL_FORMULA_AND_STRUC"><h2 id="_Trisalicylate_CHEMICAL_FORMULA_AND_STRUC_">CHEMICAL FORMULA AND STRUCTURE</h2><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figTrisalicylateTe"><a href="/books/NBK547963/table/Trisalicylate.Te/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figTrisalicylateTe" rid-ob="figobTrisalicylateTe"><img class="small-thumb" src="/books/NBK547963/table/Trisalicylate.Te/?report=thumb" src-large="/books/NBK547963/table/Trisalicylate.Te/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="Trisalicylate.Te"><a href="/books/NBK547963/table/Trisalicylate.Te/?report=objectonly" target="object" rid-ob="figobTrisalicylateTe">Table</a></h4></div></div></div><div id="Trisalicylate.CITED_REFERENCE"><h2 id="_Trisalicylate_CITED_REFERENCE_">CITED REFERENCE</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="Trisalicylate.REF.1">Cersosimo RJ, Matthews SJ. Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity. <span><span class="ref-journal">Drug Intell Clin Pharm. </span>1987;<span class="ref-vol">21</span>:621–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3301251" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3301251</span></a>]</div></dd></dl></dl></div><div id="Trisalicylate.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Trisalicylate_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 15 August 2020</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Trisalicylate.REF.zimmerman.1999">Zimmerman HJ. Drugs used to treat rheumatic and musculospastic disease. Chapter 19: The NSAIDS. In Zimmerman, HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott Williams & Williams, 1999, pp. 517-41.<div><i>(Review of hepatotoxicity of salicylates published in 1999, discusses aspirin).</i></div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.lewis.2013">Lewis JH, Stine JG. Nonsteroidal anti-inflammatory drugs and leukotriene receptor antagonists: pathology and clinical presentation of hepatotoxicity. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd Edition. Amsterdam: Elsevier, 2013. pp. 370-402.<div><i>(Expert review of liver injury caused by NSAIDs mentions that choline magnesium trisalicylate can cause hypersensitivity reactions and accompanying liver injury).</i></div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.burke.2006">Burke A, Smyth E, FitzGerald GA. Analgesic-antipyretic and antiinflammatory agents: pharmacotherapy of gout. Chapter 26. In, Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill, 2006, pp 671-715.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.blechman.1979.119">Blechman WJ, Lechner BL. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis. <span><span class="ref-journal">Rheumatol Rehabil. </span>1979;<span class="ref-vol">18</span>:119–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/377449" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 377449</span></a>]<div>
|
|
<i>(Comparison of trisalicylate with aspirin in rheumatoid arthritis; trisalicylate was as effective and had fewer side effects, and no abnormal laboratory results were found on testing after 7 weeks of therapy).</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.cersosimo.1987.621">Cersosimo RJ, Matthews SJ. Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity. <span><span class="ref-journal">Drug Intell Clin Pharm. </span>1987;<span class="ref-vol">21</span>:621–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3301251" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3301251</span></a>]<div>
|
|
<i>(21 year old woman with lupus developed rising serum aminotransferase levels when placed on trisalicylate, resolving with discontinuation: no jaundice: Case 1).</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.le_gallez.1990.71">Le Gallez P, Bird HA, Wright V. A comparison of choline magnesium trisalicylate and acetylsalicylic acid in patients with rheumatoid arthritis. <span><span class="ref-journal">Curr Med Res Opin. </span>1990;<span class="ref-vol">12</span>:71–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2202551" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2202551</span></a>]<div>
|
|
<i>(Crossover 3 week study in 19 patients with rheumatoid arthritis with ALT monitoring, "as far as one could tell, there was no significant differences in the frequency of side-effects").</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.nadkarni.1992.151">Nadkarni MM, Peller CA, Retig J. Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate. <span><span class="ref-journal">Am J Gastroenterol. </span>1992;<span class="ref-vol">87</span>:151–3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1728115" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1728115</span></a>]<div>
|
|
<i>(66 year old woman developed jaundice 3 days after stopping 3 day course of trisalicylate for osteoarthritis [bilirubin 7.0 rising to 14.3 mg/dL, ALT 774 U/L, Alk P 542 U/L], with severe course, but ultimate recovery; biopsy showed hepatitis with eosinophils; no rash or fever, ANA negative).</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.chalasani.2008.1924">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J., Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. <span><span class="ref-journal">Gastroenterology. </span>2008;<span class="ref-vol">135</span>:1924–34.</span> [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18955056" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div>
|
|
<i>(Among 300 cases of drug induced liver disease in the US collected from 2004 to 2008, NSAIDs were implicated as a sole agent in 8 cases [4 diclofenac, 2 celecoxib, 1 meloxicam and 1 oxaprozin] and as one of several agents in 3 cases [1 diclofenac, 1 celecoxib, 1 ibuprofen]; trisalicylate not mentioned).</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.bj_rnsson.2013.1419">Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. <span><span class="ref-journal">Gastroenterology. </span>2013;<span class="ref-vol">144</span>:1419–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23419359" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23419359</span></a>]<div>
|
|
<i>(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, none of which were due to choline magnesium trisalicylate or other salicylates).</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.hern_ndez.2014.231">Hernández N, Bessone F, Sánchez A, di Pace M, Brahm J, Zapata R, A, Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. <span><span class="ref-journal">Ann Hepatol. </span>2014;<span class="ref-vol">13</span>:231–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24552865" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div>
|
|
<i>(Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases, none of which were due to choline magnesium trisalicylate or other salicylates).</i>
|
|
</div></div></li><li><div class="bk_ref" id="Trisalicylate.REF.chalasani.2015.1340">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al. United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">148</span>:1340–52.e7.</span> [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25754159" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div>
|
|
<i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 28 were due to nonsteroid antiinflammatory agents, one to salsalate but none to choline magnesium trisalicylate).</i>
|
|
</div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK547963_pubdet_">Publication Details</h2><h3>Publication History</h3><p class="small">Last Update: <span itemprop="dateModified">August 15, 2020</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p><a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Trisalicylate. [Updated 2020 Aug 15].<span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/livertox/Triptorelin/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/livertox/Troglitazone/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobTrisalicylateTc"><div id="Trisalicylate.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547963/table/Trisalicylate.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Trisalicylate.Tc_lrgtbl__"><table><tbody><tr><th id="hd_b_Trisalicylate.Tc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Medication:</th><td headers="hd_b_Trisalicylate.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Choline magnesium trisalicylate (3.0 g daily)</td></tr><tr><th id="hd_b_Trisalicylate.Tc_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pattern:</th><td headers="hd_b_Trisalicylate.Tc_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Mixed (R=4.5)</td></tr><tr><th id="hd_b_Trisalicylate.Tc_1_1_3_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Severity:</th><td headers="hd_b_Trisalicylate.Tc_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1+ (enzyme elevations without jaundice)</td></tr><tr><th id="hd_b_Trisalicylate.Tc_1_1_4_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Latency:</th><td headers="hd_b_Trisalicylate.Tc_1_1_4_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">4 days</td></tr><tr><th id="hd_b_Trisalicylate.Tc_1_1_5_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Recovery:</th><td headers="hd_b_Trisalicylate.Tc_1_1_5_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rapid, but not documented to be complete</td></tr><tr><th id="hd_b_Trisalicylate.Tc_1_1_6_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Other medications:</th><td headers="hd_b_Trisalicylate.Tc_1_1_6_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">None mentioned</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobTrisalicylateTd"><div id="Trisalicylate.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547963/table/Trisalicylate.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Trisalicylate.Td_lrgtbl__"><table><thead><tr><th id="hd_h_Trisalicylate.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Time After<br />Starting</th><th id="hd_h_Trisalicylate.Td_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Time After<br />Stopping</th><th id="hd_h_Trisalicylate.Td_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">ALT<br />(U/L)</th><th id="hd_h_Trisalicylate.Td_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Alk P<br />(U/L)</th><th id="hd_h_Trisalicylate.Td_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Bilirubin<br />(mg/dL)</th><th id="hd_h_Trisalicylate.Td_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pre</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pre</td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">79</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">164</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.8</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Admission for fever and headache</td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pre</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">84</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">290</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.4</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IgM anti-CMV positive</td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pre</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">15</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">100</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.6</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_3 hd_h_Trisalicylate.Td_1_1_1_4 hd_h_Trisalicylate.Td_1_1_1_5 hd_h_Trisalicylate.Td_1_1_1_6" colspan="4" rowspan="1" style="text-align:center;vertical-align:top;">Trisalicylate started (1.5 g twice daily)</td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">63</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">357</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.2</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">6 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0</td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">555</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">371</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.3</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Trisalicylate stopped</td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">7 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1 day</td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">590</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">376</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.3</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">8 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">2 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">383</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">326</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.5</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">9 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3 days</td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">190</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">275</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.4</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_Trisalicylate.Td_1_1_1_3 hd_h_Trisalicylate.Td_1_1_1_4 hd_h_Trisalicylate.Td_1_1_1_5 hd_h_Trisalicylate.Td_1_1_1_6" colspan="4" rowspan="1" style="text-align:center;vertical-align:top;">Patient discharged; no follow up available</td></tr><tr><td headers="hd_h_Trisalicylate.Td_1_1_1_1 hd_h_Trisalicylate.Td_1_1_1_2" colspan="2" scope="row" rowspan="1" style="text-align:center;vertical-align:top;">
|
|
<b>Normal Values</b>
|
|
</td><td headers="hd_h_Trisalicylate.Td_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
|
|
<b><41</b>
|
|
</td><td headers="hd_h_Trisalicylate.Td_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
|
|
<b><110</b>
|
|
</td><td headers="hd_h_Trisalicylate.Td_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
|
|
<b><1.2</b>
|
|
</td><td headers="hd_h_Trisalicylate.Td_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobTrisalicylateTe"><div id="Trisalicylate.Te" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547963/table/Trisalicylate.Te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Trisalicylate.Te_lrgtbl__"><table><thead><tr><th id="hd_h_Trisalicylate.Te_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DRUG</th><th id="hd_h_Trisalicylate.Te_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CAS REGISTRY NO</th><th id="hd_h_Trisalicylate.Te_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Trisalicylate.Te_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Trisalicylate.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Choline Magnesium Salicylate</td><td headers="hd_h_Trisalicylate.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/135008043" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">64425-90-7</a>
|
|
</td><td headers="hd_h_Trisalicylate.Te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">C7-H6-O3.C7-H5-O3.<br /> C5-H14-N-O.1/2Mg</td><td headers="hd_h_Trisalicylate.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/135008043" title="View this structure in PubChem" class="img_link" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem"><img src="https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=l&sid=135008043" alt="image 135008043 in the ncbi pubchem database" /></a>
|
|
</td></tr></tbody></table></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|